Torrent House
Off Ashram Road
Ahmedabad 380009
India
91 79 2659 9000
https://www.torrentpharma.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 13 247
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Samir Uttamlal Mehta B.Com., MBA | Executive Chairman & MD | 230,04M | S.O. | 1964 |
Mr. Jinesh Shah B.Sc., MBA | Executive Director of Operations & Whole Time Director | 58,87M | S.O. | 1977 |
Mr. Aman Mehta | Whole-Time Director | 20,59M | S.O. | S.O. |
Mr. Sudhir Menon CA, CWA | Executive Director of Finance & CFO | 16,3M | S.O. | 1972 |
Mr. Chintan Trivedi | Company Secretary & Compliance Officer | S.O. | S.O. | S.O. |
Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer | S.O. | S.O. | S.O. |
Jaydip Bhatt | Vice President of Human Resource | S.O. | S.O. | 1953 |
Ashish Hajarnish M.Pharm | Vice President of Works | S.O. | S.O. | 1968 |
Hasmukh Patel B.Pharm, M.Pharm. | Vice President of Works | S.O. | S.O. | 1968 |
Kaushal Solanki CA | Vice President of Finance | S.O. | S.O. | 1967 |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
L’ISS Governance QualityScore de Torrent Pharmaceuticals Limited en date du 1 mai 2024 est 7. Les scores principaux sont Audit : 3; Société : 8; Droits des actionnaires : 9; Compensation : 5.